1-5 of 5
Lode J. Swinnen
Close
Sort by
Journal Articles

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Clinical Trials & Observations
Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina Wagner-Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3189–3199.
https://doi.org/10.1182/bloodadvances.2023011657
Published: 2024
Includes: Supplemental data
Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Clinical Trials & Observations
Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020001729
Published: 2020
Includes: Supplemental data
Journal Articles

Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Clinical Trials & Observations
Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F. Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2608–2616.
https://doi.org/10.1182/bloodadvances.2019000155
Published: 2019
Includes: Supplemental data
Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2226–2229.
https://doi.org/10.1182/bloodadvances.2018019208
Published: 2018
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data